Log In
Or create an account ->
Imperial Library
Home
About
News
Upload
Forum
Help
Login/SignUp
Index
THE PROPAGANDA FOR REFORM IN Proprietary Medicines
PREFACE TO VOLUME 2
PREFACE TO VOLUME 1: NINTH EDITION
RESOLUTION ENDORSING THE WORK OF THE COUNCIL ON PHARMACY AND CHEMISTRY
Presented at the San Francisco Session and Signed by All the Members of the House of Delegates in Attendance
TABLE OF CONTENTS
PART I REPORTS OF THE COUNCIL ON PHARMACY AND CHEMISTRY
FOREWORD
THE COUNCIL ON PHARMACY AND CHEMISTRY
OFFICIAL RULES OF THE COUNCIL ON PHARMACY AND CHEMISTRY
Introduction
Rules Governing the Admission of Proprietary Articles to the Book New and Nonofficial Remedies
Explanatory Comments on the Rules
Explanation of Rule 1: Composition
Explanation of Rule 2: Identification
Explanation of Rule 3: Direct Advertising
Explanation of Rule 4: Indirect Advertising
Explanation of Rule 5: False Claims as to Origin
Explanation of Rule 6: Unwarranted Therapeutic Claims
Explanation of Rule 7: Poisonous Substances
Explanation of Rule 8: Objectionable Names
Explanation of Rule 9: Patents, Trademarks, Copyrights, Etc.
Explanation of Rule 10: Unscientific and Useless Articles
THE COUNCIL ON PHARMACY AND CHEMISTRY, PRESENT AND FUTURE [A]
“ACCEPTED BY THE COUNCIL ON PHARMACY AND CHEMISTRY”
HELPING THE COUNCIL
DELAYS IN PASSING ON PRODUCTS
Report of the Council on Pharmacy and Chemistry
COOPERATION OF THE PHARMACEUTICAL HOUSES
Report of the Council on Pharmacy and Chemistry
BUDWELL’S EMULSION OF COD-LIVER OIL, NOS. 1 AND 2
Report of the Council on Pharmacy and Chemistry
RHEUMALGINE
Report of the Council on Pharmacy and Chemistry
GRAY’S GLYCERINE TONIC
Report of the Council on Pharmacy and Chemistry
TONGALINE AND PONCA COMPOUND
Report of the Council on Pharmacy and Chemistry
ALFATONE
Report of the Council on Pharmacy and Chemistry
ARTICLES REFUSED RECOGNITION
Report of the Council on Pharmacy and Chemistry
Uricsol
Jubol
Urodonal
FORMAMINT
Report of the Council on Pharmacy and Chemistry
Experimental Data
Discussion
HYDRAGOGIN
Report of the Council on Pharmacy and Chemistry
FILUDINE
Report of the Council on Pharmacy and Chemistry
LACTOPEPTINE AND ELIXIR LACTOPEPTINE
Report of the Council on Pharmacy and Chemistry
Manufacturers’ Protest and Council’s Answer
Report of Referee A
Report of Referee B
IODUM-MILLER AND IOD-IZD-OIL (MILLER’S)
Report of the Council on Pharmacy and Chemistry
ELIXIR IODO-BROMIDE OF CALCIUM COMP. “WITHOUT MERCURY” AND “WITH MERCURY”
Report of the Council on Pharmacy and Chemistry
LECITHIN PREPARATIONS OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
Lecithin Preparations
PROPRIETARY NAMES FOR LIQUID PETROLATUM
Report of the Council on Pharmacy and Chemistry
SENG
Report of the Council on Pharmacy and Chemistry
FROSST’S BLAUD CAPSULES
Report of the Council on Pharmacy and Chemistry
TYREE’S ELIXIR OF BUCHU AND HYOSCYAMUS COMPOUND
Report of the Council on Pharmacy and Chemistry
HYDROLEINE
Report of the Council on Pharmacy and Chemistry
CURATIVE VACCINE, BRUSCHETTINI
Report of the Council on Pharmacy and Chemistry
STEARNS’ WINE
Report of the Council on Pharmacy and Chemistry
PROTONUCLEIN AND PROTONUCLEIN BETA
Report of the Council on Pharmacy and Chemistry
HYDROPSIN
Report of the Council on Pharmacy and Chemistry
DIGITALYSATUM
Report of the Council on Pharmacy and Chemistry
SO-CALLED SECRETIN PREPARATIONS
Report of the Council on Pharmacy and Chemistry
HAS SECRETIN A THERAPEUTIC VALUE? [B][C]
ARTICLES REFUSED RECOGNITION
Report of the Council on Pharmacy and Chemistry
Radio-Rem
Olio-Phlogosis
THE HYPOPHOSPHITE FALLACY
Report of the Council on Pharmacy and Chemistry
PULVOIDS CALCYLATES
Report of the Council on Pharmacy and Chemistry
SULFURYL MONAL
Report of the Council on Pharmacy and Chemistry
MARK WHITE GOITER SERUM AND MARK WHITE IODINIZED OIL
Report of the Council on Pharmacy and Chemistry
Editorial Note on the Mark White “Serum”
KORA-KONIA
Report of the Council on Pharmacy and Chemistry
THE THERAPEUTIC VALUE OF THE GLYCEROPHOSPHATES
Report of the Council on Pharmacy and Chemistry
HYDRAS
Report of the Council on Pharmacy and Chemistry
BROMIN-IODIN COMPOUND
Report of the Council on Pharmacy and Chemistry
AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
ALPHOZONE OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
CALCIUM GLYCEROPHOSPHATE AND SODIUM GLYCEROPHOSPHATE OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
GARDNER’S SYRUP OF AMMONIUM HYPOPHOSPHITE OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
GLUTEN PRODUCTS MADE BY THE KELLOGG FOOD COMPANY
Report of the Council on Pharmacy and Chemistry
Referee’s Report
IODO-MANGAN OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
LIQUID ALBOLENE
Report of the Council on Pharmacy and Chemistry
NAPHEY’S MEDICATED UTERINE WAFERS
Report of the Council on Pharmacy and Chemistry
NUJOL
Report of the Council on Pharmacy and Chemistry
PULVOIDS NATRIUM COMPOUND
Report of the Council on Pharmacy and Chemistry
SALOFORM
Report of the Council on Pharmacy and Chemistry
SECRETOGEN
Report of the Council on Pharmacy and Chemistry
IRON CITRATE GREEN
Report of the Council on Pharmacy and Chemistry
ASPIRIN
Report of the Council on Pharmacy and Chemistry
PIL. CASCARA COMPOUND-ROBINS
Report of the Council on Pharmacy and Chemistry
CASTA-FLORA
Report of the Council on Pharmacy and Chemistry
FIRWEIN
Report of the Council on Pharmacy and Chemistry
FIROLYPTOL PLAIN AND FIROLYPTOL WITH KREOSOTE
Report of the Council on Pharmacy and Chemistry
BINIODOL
Report of the Council on Pharmacy and Chemistry
COMPARATIVE SYMPTOMS RESULTING FROM THE USE OF SEVERAL OILY SUSPENSIONS OF RED MERCURIC IODID (MERCURY BINIODID)
Report of Dr. H. N. Cole[D]
Report of Dr. Albert Keidel
CORPORA LUTEA (SOLUBLE EXTRACT), PARKE, DAVIS & CO.
Report of the Council on Pharmacy and Chemistry
WHEELER’S TISSUE PHOSPHATES
Report of the Council on Pharmacy and Chemistry
WHEELER’S TISSUE PHOSPHATES
THE CLAIMED GALACTAGOGUE EFFECTS OF NUTROLACTIS AND GOAT’S RUE NOT SUBSTANTIATED
Report of the Council on Pharmacy and Chemistry
THE ALLEGED GALACTAGOGUE ACTION OF GALEGA AND NUTROLACTIS [E][F]
THE RUSSELL EMULSION AND THE RUSSELL PREPARED GREEN BONE
Report of the Council on Pharmacy and Chemistry
BROM-I-PHOS
Report of the Council on Pharmacy and Chemistry
CREOSOTE-DELSON AND CREOFOS
Report of the Council on Pharmacy and Chemistry
TRINER’S AMERICAN ELIXIR OF BITTER WINE
Report of the Council on Pharmacy and Chemistry
TRIMETHOL
Report of the Council on Pharmacy and Chemistry
FERRIVINE, INTRAMINE AND COLLOSOL IODINE
Report of the Council on Pharmacy and Chemistry
ESKAY’S NEURO PHOSPHATES
Report of the Council on Pharmacy and Chemistry
K-Y LUBRICATING JELLY
Report of the Council on Pharmacy and Chemistry
ZIRATOL
Report of the Council on Pharmacy and Chemistry
GONOSAN
Report of the Council on Pharmacy and Chemistry
Appendix
ALCRESTA IPECAC
Report of the Council on Pharmacy and Chemistry
IODEOL AND IODAGOL
Report of the Council on Pharmacy and Chemistry
Summary of Referee’s Report
CAPSULES BISMUTH RESORCINOL COMPOUND NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
DIXON’S TUBERCLE BACILLI EXTRACT AND DIXON’S SUSPENSION OF DEAD TUBERCLE BACILLI
Report of the Council on Pharmacy and Chemistry
FORMOSOL
Report of the Council on Pharmacy and Chemistry
IODOLENE, A SOLUTION OF IODIN IN LIQUID PETROLATUM, INADMISSIBLE TO N. N. R.
Report of the Council on Pharmacy and Chemistry
KALAK WATER
Report of the Council on Pharmacy and Chemistry
MINSON’S SOLUBLE IODIN “KELPIDINE” NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
NUTONE
Report of the Council on Pharmacy and Chemistry
TRI-ARSENOLE, L. O. COMPOUND NO. 1 AND L. O. COMPOUND NO. 2
Report of the Council on Pharmacy and Chemistry
UNCTOL
Report of the Council on Pharmacy and Chemistry
V-E-M (SCHOONMAKER LABORATORIES, INC.)
Report of the Council on Pharmacy and Chemistry
HEMO-THERAPIN
Report of the Council on Pharmacy and Chemistry
VENOSAL
Report of the Council on Pharmacy and Chemistry
SECRETIN-BEVERIDGE AND THE U. S. PATENT LAW
Report of the Council on Pharmacy and Chemistry
THE QUESTION OF THE STABILITY OF SECRETIN
NEED FOR PATENT LAW REVISION
Report of the Committee on Patent-Law Revision of the Council on Pharmacy and Chemistry of the American Medical Association
SURGODINE
Report of the Council on Pharmacy and Chemistry
MEDEOL SUPPOSITORIES
Report of the Council on Pharmacy and Chemistry
GUAIODINE
Report of the Council on Pharmacy and Chemistry
SEVERAL “MIXED” VACCINES NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
Mixed Vaccines-Abbott
Catarrhal Vaccine Combined-Lilly and Influenza Mixed Vaccine-Lilly
Influenza Serobacterin Mixed-Mulford
Sherman’s Mixed Vaccine No. 40
OPHTHALMOL-LINDEMANN
Report of the Council on Pharmacy and Chemistry
SILVOL INELIGIBLE FOR N. N. R.
Report of the Council on Pharmacy and Chemistry
KATHARMON
Report of the Council on Pharmacy and Chemistry
IODINIZED EMULSION (SCOTT) AND CREOSOTONIC (SCOTT)
Report of the Council on Pharmacy and Chemistry
Iodinized Emulsion (Scott)
Creosotonic (Scott)
CAMPETRODIN AND CAMPETRODIN NO. 2
Report of the Council on Pharmacy and Chemistry
CARMINZYM
Report of the Council on Pharmacy and Chemistry
PHILLIPS’ PHOSPHO-MURIATE OF QUININE COMP.
Report of the Council on Pharmacy and Chemistry
B. IODINE AND B. OLEUM IODINE
Report of the Council on Pharmacy and Chemistry
B. IODINE PRODUCTS
ANTITHYROID PREPARATIONS (ANTITHYROIDIN-MOEBIUS AND THYREOIDECTIN) OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
CEPHAELIN AND SYRUP CEPHAELIN-LILLY OMITTED FROM N. N. R. AND SYRUP EMETIC-LILLY NOT ACCEPTED
Report of Council on Pharmacy and Chemistry
COLALIN OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
FORAL
Report of the Council on Pharmacy and Chemistry
GRANULAR EFFERVESCENT BROMIDE AND ACETANILID COMPOUND-MULFORD
Report of the Council on Pharmacy and Chemistry
HOLADIN AND BILE SALT MIXTURES
Report of the Council on Pharmacy and Chemistry
LIQUOR SANTAIVA, S. & D., OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
MALTZYME, MALTZYME WITH CASCARA SAGRADA, MALTZYME WITH COD LIVER OIL, MALTZYME FERRATED AND MALTZYME WITH YERBA SANTA OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
METHAFORM OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
PINEAL GLAND, RED BONE-MARROW AND THYMUS GLAND AND THEIR PREPARATIONS OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
Pineal Gland
Red Bone-Marrow
Thymus Gland
PIPERAZINE AND LYCETOL OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
STANOLIND LIQUID PARAFFIN OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
WESTERFIELD’S DIGITALIS TABLETS
Report of the Council on Pharmacy and Chemistry
XEROFORM-HEYDEN AND BISMUTH TRIBROMPHENATE-MERCK OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
CREAM OF MUSTARD REFUSED RECOGNITION
Report of the Council on Pharmacy and Chemistry
“PLURIGLANDULAR” MIXTURES
Report of the Council on Pharmacy and Chemistry
CERELENE NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
COLLOSOL COCAINE NOT ADMITTED TO N. N. R
Report of the Council on Pharmacy and Chemistry
CUPRASE NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
COLLOSOL PREPARATIONS
Report of the Council on Pharmacy and Chemistry
Additional Notes on Collosol Evidence
PULVOIDS CALCYLATES COMPOUND
Report of the Council on Pharmacy and Chemistry
PROTEOGENS OF THE WM. S. MERRELL COMPANY
Report of the Council on Pharmacy and Chemistry
Report of First Referee on Proteogens
Report of Second Referee Reviewing Manufacturers’ Reply
“ARSENOVEN S. S.” AND “ARSENO-METH-HYD”
Report of the Council on Pharmacy and Chemistry
HORMOTONE AND HORMOTONE WITHOUT POST-PITUITARY
Report of the Council on Pharmacy and Chemistry.
FORMALDEHYDE LOZENGES
Report of the Council on Pharmacy and Chemistry
Hex-Iodin
Formitol Tablets
Cin-U-Form Lozenges
LAVORIS
Report of the Council on Pharmacy and Chemistry
MEDINAL
Report of the Council on Pharmacy and Chemistry
OMISSION OF COTARNIN SALTS (STYPTICIN AND STYPTOL) FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
MICAJAH’S WAFERS AND MICAJAH’S SUPPOSITORIES
Report of the Council on Pharmacy and Chemistry
ALKALITHIA
Report of the Council on Pharmacy and Chemistry
ARHOVIN OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
CHLORON, CHLORAX AND NUMBER “3”
Report of the Council on Pharmacy and Chemistry
Chloron
Chlorax
Number “3”
ELARSON OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
IODIPHOS
Report of the Council on Pharmacy and Chemistry
MERVENOL AND ARMERVENOL NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
NORMAL PHENOL SERUM (CANO) AND METHYL-PHENOL SERUM (CANO) NOT ACCEPTED FOR N. N. R.
Report of the Council on Pharmacy and Chemistry
SOAMIN OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
SOME MIXED VACCINES NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
SOMNOFORM
Report of the Council on Pharmacy and Chemistry
TABLETS FORMOTHALATES
Report of the Council on Pharmacy and Chemistry
TRIPLE ARSENATES WITH NUCLEIN
Report of the Council on Pharmacy and Chemistry
“ANTI-PNEUMOCOCCIC OIL” AND THE USE OF CAMPHOR IN PNEUMONIA
Report of the Council on Pharmacy and Chemistry
DIAL “CIBA”
Report of the Council on Pharmacy and Chemistry
APOTHESINE
Report of the Council on Pharmacy and Chemistry
EUMICTINE
Report of the Council on Pharmacy and Chemistry
PLATT’S CHLORIDES
Report of the Council on Pharmacy and Chemistry
ANTI-TUBERCULOUS LYMPH COMPOUND (SWEENY) AND ANTI-SYPHILITIC COMPOUND (SWEENY)
Report of the Council on Pharmacy and Chemistry
Anti-Tuberculous Lymph Compound (Sweeny)
Anti-Syphilitic Compound (Sweeny)
SYRUP LEPTINOL (FORMERLY SYRUP BALSAMEA)
Report of the Council on Pharmacy and Chemistry
FORMITOL TABLETS, II
Report of the Council on Pharmacy and Chemistry
SUKRO-SERUM AND APHLEGMATOL
Report of the Council on Pharmacy and Chemistry
SUPSALVS NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
HYPODERMIC SOLUTION NO. 13, IRON, ARSENIC AND PHOSPHORUS COMPOUND NOT ACCEPTED FOR N. N. R.
Report of the Council on Pharmacy and Chemistry
PARATHESIN NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
CHLORLYPTUS
Report of the Council on Pharmacy and Chemistry
I. DETAILED REPORTS
Summarized Reports
II. APPENDIX: SPECIAL REPORTS
A. COMPARISON OF CHLORLYPTUS WITH CHLORINATED EUCALYPTOL
From the Chemical Laboratory of the American Medical Association
B. THE PERSISTENCE OF THE ACID
Reaction of Chlorlyptus in the Body
C. TOXICITY EXPERIMENTS
D. REPORT OF DR. D. RIVAS
AQUAZONE (OXYGEN WATER)
Report of the Council on Pharmacy and Chemistry
COAGULEN-CIBA OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
FERRIC CACODYLATE OMITTED FROM NEW AND NONOFFICIAL REMEDIES
Report of the Council on Pharmacy and Chemistry
LIBRADOL
Report of the Council on Pharmacy and Chemistry
HELMITOL OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
SPIROCIDE NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
DIGIFOLIN-CIBA NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
SOME OF LOESER’S INTRAVENOUS SOLUTIONS
Report of the Council on Pharmacy and Chemistry
“NATIONAL IODINE SOLUTION” NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
MON-ARSONE NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
OXYL-IODIDE NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
QUASSIA COMPOUND TABLETS
Report of the Council on Pharmacy and Chemistry
TOXICIDE
Report of the Council on Pharmacy and Chemistry
PIL. MIXED TREATMENT (CHICHESTER)
Report of the Council on Pharmacy and Chemistry
ATOPHAN OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
UROTROPIN OMITTED FROM N. N. R.
Report of the Council on Pharmacy and Chemistry
Commercial History of Hexamethylenamin
Urotropin Marketed Under Unwarranted Therapeutic Claims
Urotropin a Brand of Hexamethylenamine, U. S. P.
STYPTYSATE NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
LIPOIDAL SUBSTANCES (HOROVITZ) NOT ADMITTED TO N. N. R.
Report of the Council on Pharmacy and Chemistry
YEAST PREPARATIONS AND VITAMIN B CONCENTRATES
Report of the Council on Pharmacy and Chemistry
PART II CONTRIBUTIONS FROM THE A. M. A. CHEMICAL LABORATORY
FOREWORD
THE CHEMICAL LABORATORY OF THE AMERICAN MEDICAL ASSOCIATION
THE WORK OF THE AMERICAN MEDICAL ASSOCIATION CHEMICAL LABORATORY[G]
LEAD IN “AKOZ”
Details of Analysis
SODIUM ACETATE IN WARMING BOTTLES
ANTI-SYPHILITIC COMPOUND (SWEENY)
“AMBRINE” AND PARAFFIN FILMS[H]
Addenda
THE STABILITY OF IODINE OINTMENTS
IODOLENE AND THE SOLUBILITY OF IODIN IN LIQUID PETROLATUM
AMERICAN-MADE SYNTHETIC DRUGS—I
Examination of American-Made Acetylsalicylic Acid
THE STANDARDIZATION OF COMMERCIAL BISMUTH TRIBROMPHENATE
Report to Council of National Defense
Revision of N. N. R. Standards
THE STANDARDIZATION OF PROCAIN AND EXAMINATION OF THE MARKET SUPPLY
DETERIORATION OF SODIUM HYPOCHLORITE SOLUTIONS (“Chlorinated Soda” Solutions)
SYPHILODOL
Details of Analysis
CERELENE
DR. DE SANCTIS’ RHEUMATIC AND GOUT PILLS
IODEX AND LIQUID IODEX
Details of Analysis
I. G. O.
IODIN IN LIQUID PETROLATUM
AMERICAN-MADE SYNTHETIC DRUGS—II
Examination of Procain (Novocain), Barbital (Veronal), Phenetidyl-Acetphenetidin (Holocain), Cinchophen or Phenylcinchoninic Acid (Atophan), Manufactured Under Federal Trade Commission Licenses[I][J]
PART III CONTRIBUTIONS FROM THE JOURNAL: PROPRIETARY PRODUCTS
NOSTRUMS IN RETROSPECT
A Series of Nine Articles Reviewing Worthless or Unscientific Proprietary Mixtures Previously Criticized
[Article I]
Bell-Ans (Pa-Pay-Ans Bell)[K]
[Article II]
Anasarcin and Anedemin
[Article III]
Pepto-Mangan
[Article IV]
Cactina Pillets
[Article V]
Ammonol and Phenalgin
[Article VI]
Fellows’ Syrup, and Other Preparations of the Hypophosphites
[Article VII]
Shotgun Nostrums
[Article VIII]
Tyree’s Antiseptic and Aseptinol
[Article IX]
Neurosine and the Original Package Evil
ANASARCIN ADVERTISING[L]
ANTIMERISTEM-SCHMIDT
ANTIPHLOGISTINE
“AUTO-HEMIC SERUM”
A Cure for Laziness, Ugliness, Frigidity and Many Other Things
“AUTOLYSIN” ADVERTISING
“BASIC CANCER RESEARCH” AND “COSMOPOLITAN CANCER RESEARCH SOCIETY”
Seleni-Bascca
Repudiated by the Brooklyn Bureau of Charities
BELL-ANS (PAPAYANS, BELL)[M]
As the New York Tribune’s “Ad-Visor” Sees It
CAMPHO-PHENIQUE
Appealing to the New Fledged Graduate.
“CINCHOPHEN”: FORMERLY “ATOPHAN”
“COLLOSOLS”: AN UNCRITICAL ENGLISH ENDORSEMENT
Collosol Manganese
COTTON PROCESS ETHER
A Note from the Manufacturers
DIONOL
Glorified Petrolatum
THE ELI PRODUCTS OF ELI H. DUNN
GLOVER’S CANCER SERUM
The Toronto Academy of Medicine Reports Unfavorably on Glover’s Cancer Serum
GLYCO-THYMOLINE AND POLIOMYELITIS
GLYKERON: COLD STORAGE TESTIMONIALS [N]
GRAY’S GLYCERINE TONIC: “WHOSE BREAD I EAT HIS SONG I SING”
HAGEE’S CORDIAL OF COD LIVER OIL
HYPNO-BROMIC COMPOUND
INTRAVENOUS COMPOUND (LOFFLER)
Its Composition and the Peculiar Methods by Which It Is Exploited
INTRAVENOUS SPECIALTIES
IODEX
THE WILLIAM F. KOCH CANCER REMEDY
Further Comment
THE LUCAS LABORATORIES’ PRODUCTS
“PHYLACOGENS” [O]
PINEOLEUM ADVERTISING METHODS
Capitalizing the Name and Position of the President of the American Medical Association
“PROTEAL THERAPY” AND HENRY SMITH WILLIAMS
PROTEOGENS
Commercial Therapeutics [P]
An Alleged Endorsement of Proteogens Repudiated
The Manufacturer’s Protest and a Reply
Details of the Alleged Endorsement of Proteogens
Dr. Broeman’s Final Report on Proteogens
PULVANE
SAL HEPATICA
SALICON
SO-CALLED SECRETIN PREPARATIONS
SUCCUS CINERARIA MARITIMA
Another Illustration of One of the Weaknesses of the Federal Food and Drugs Act
TEKARKIN
Edward Percy Robinson’s “Cure” for Cancer
TYREE’S ANTISEPTIC POWDER AGAIN
The “Ethical and Commercial Requirements” of the Drug Business
WHEELER’S TISSUE PHOSPHATES
BRIEFER PARAGRAPHS
Alcresta Lotion
Calcidin Tablets (Abbott)
Di-Crotalin Treatment of Epilepsy
Estivin
Iron Arsenite
K-Y Lubricating Jelly
“Nikalgin”
Pertussin and Syrup of Thyme
Quinin and Urea Hydrochlorid
Ricord Pills and House Organ Therapeutics
Stannoxyl
Syphilodol
Thialion
PART IV CONTRIBUTIONS FROM THE JOURNAL: MISCELLANY
ALBERT ABRAMS, A.M., M.D., LL.D., F.R.M.S.
“Spondylotherapy,” “Electronic Reactions,” the “Oscilloclast,” the “Electrobioscope,” Etc.
Dr. Abrams’ Graduation
A Defense by Upton Sinclair
Comment
ACETYLSALICYLIC ACID, NOT ASPIRIN
“What’s in a Name?”
Advertising Principles—Lay and Medical
“Aspirin”—A Common Name
“Aspirin Bayer” and the Sterling Products Company
THE ALLIED MEDICAL ASSOCIATIONS OF AMERICA
Another Rocket in the Pyrotechnics of Quasimedical Organizations
“ARSENICALS”
Pharmacology of Arsenicals
Salvarsan: Abrogate the Patent
End the Monopoly
Arsphenamin
BEER AND CANCER CURES
Did the Brewing Interests Advertise Autolysin?
BIOLOGIC THERAPEUTICS AND ITS COMMERCIAL DOMINATION
CAPELL’S UROLUETIC TEST
Another Urinary Test for Syphilis
CHEMOTHERAPY AND TUMORS [Q][R]
Richard Weil, M.D., New York
THE DIRECT SALES COMPANY
DISCOVERIES AND DISCOVERERS
“DRUG REFORM”
As It Appears to the Cleveland Medical Journal
DRUG THERAPY: THE FALLIBILITY OF TEXTBOOKS
THOMAS WEBSTER EDGAR
Tired Rabbits for Diabetes; Ring-Tailed Monkeys for Sex Stimulation
The Journal Receives a Letter Denouncing “Medical Clerks” and “Biased Sceptres”
GLYCEROPHOSPHATES
INFLUENZA VACCINES
Serums and Vaccines
INTRAVENOUS THERAPY
IODIN FUMES
ITALIAN PHYSICO-CHEMICAL COMPANY
WHAT IS LIQUID PETROLATUM?
THE LOWENTHAL POSTGRADUATE COURSE
Which Tells How to Make Diagnoses Accurately, Scientifically Check the Christian Scientists and Increase Your Earning Power
MEDICAL SOCIETY OF THE UNITED STATES
From “Division of Fees” to “Down with Autocracy”
THE NATIONAL FORMULARY—A REVIEW OF THE FOURTH EDITION
NONSPECIFIC PROTEIN THERAPY
WILLARD EALON OGDEN
A “Specialist in Proctology” and His “Clinics”
“PATENTS”
Patent Laws and Patent Office Practice
Our Archaic Patent Laws
Patents Perpetuated by Trade Names
Patenting Therapeutic Agents
PHARMACEUTICAL BARNUMS
THE PHARMACOPEIA
The Ninth Decennial Revision
Review of Ninth Revision
PHYSICIAN’S STOCK IN PRESCRIPTION PRODUCTS
PITUITARY GLAND PREPARATIONS
PROPRIETORSHIP IN MEDICINE
The Manufacturer’s Protest
Why Proprietaries Flourish
PHILIP RAHTJEN AND HIS DISCOVERIES
SODIUM CACODYLATE IN SYPHILIS
TABLETS: DEPENDABILITY OF DOSAGE
THERAPEUTIC EVIDENCE: ITS CRUCIAL TEST [S][T]
Torald Sollmann, M.D., Cleveland
“VACCINES IN TOXIC CONDITIONS”
Commercialized Propaganda in the Guise of Science
VITAMINS: THEIR DISTRIBUTION
Our Knowledge of Vitamins
The Demand for Vitamins
THE WILLIAM A. WEBSTER CO. AND THE DIRECT PHARMACEUTICAL CO.
YEAST
Yeast and Its Uses
BRIEFER PARAGRAPHS
Laxol and Lysol—The Short and Catchy Proprietary Name
Look Up Its Rating
The Medical Profession and Commercial Interests
Rabbit-Foot Therapy
Secret Remedies and the Principles of Ethics
“Sterling Violet Ray Generator”
Strontium Salicylate Not Superior to Sodium Salicylate
Vaccine As a Prophylactic in Influenza
Vaccines for “Colds”
INDEX AND BIBLIOGRAPHY
FOOTNOTES:
← Prev
Back
Next →
← Prev
Back
Next →